All Work

Jon C. Ogg

Analysts Say Sienna Biopharmaceuticals Stock Could Run 50% to 100%

The quiet period for Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA) is over after its initial public offering. The Westlake Village, California-based company recently sold just 4,983,333 shares of common stock at $15.00 per share in…

Jon C. Ogg · 9 years ago